AAPL 195.95 -0.4 (-0.20%)MSFT 133.45 +0.52 (+0.39%)FB 188.78 +0.08 (+0.04%)ZNGA 5.91 -0.04 (-0.59%)NVDA 151.96 -0.17 (-0.11%)WBA 53.16 +0.06 (+0.12%)GOOG 1086.06 +0.02 (+0.00%)PIH 5.3 0 (0.00%)
AAPL 195.95 -0.4 (-0.20%)MSFT 133.45 +0.52 (+0.39%)FB 188.78 +0.08 (+0.04%)ZNGA 5.91 -0.04 (-0.59%)NVDA 151.96 -0.17 (-0.11%)WBA 53.16 +0.06 (+0.12%)GOOG 1086.06 +0.02 (+0.00%)PIH 5.3 0 (0.00%)

Financial Statements SELB Quote Selecta Bio

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 0 3 6 0 0
COGS 0 0 0 0 0
GrossProfit 0 3 6 8 0
Depreciation (included in COGS) 0 1 1 0 0
StockBasedCompe (included in COGS) 0 1 1 2 4
ResearchAndDeve 0 10 23 30 45
SalesGeneralAnd 0 8 8 13 19
OperatingIncome 0 -15 -25 -35 -64
InterestExpense 0 1 1 1 1
OtherIncome 0 3 1 0 0
IncomeBeforeTax 0 -13 -25 -36 -65
ProvisionForInc 0 0 0 0 0
NetIncome 0 -13 -25 -36 -65
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 0 17 32 59 71
ShortTermInvest 0 0 4 25 26
Cash 0 17 36 0 0
AccountReceivab 0 1 1 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 0 1 0 0 0
TotalCurrentAss 0 19 39 87 99
PPE 0 5 5 6 6
AccumulatedDepr 0 -3 -3 -4 -4
NetPPE 0 2 2 2 2
EquityAndOtherI 0 0 0 0 0
Goodwill 0 0 0 0 0
IntangibleAsset 0 0 0 0 0
OtherLTAssets 0 1 2 0 0
TotalNonCurrent 0 3 4 2 2
TotalAssets 0 22 43 89 101
ShortTermDebt 0 3 0 4 0
AccountsPayable 0 0 2 0 0
TaxesPayable 0 0 0 0 0
AccruedLiabilit 0 1 2 0 0
DeferredRevenue 0 3 1 2 1
OtherCurrentLia 0 2 1 2 2
TotalCurrentLia 0 9 7 14 11
Debt 0 5 12 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 1 2 12 16
OtherLTLiabilit 0 95 138 0 1
TotalNonCurrent 0 101 152 21 38
TotalLiabilitie 0 110 159 34 49
CommonStock 0 0 0 0 0
AdditionalPaidI 0 0 0 211 273
RetainedEarning 0 -84 -112 -152 -217
AccumulatedOthe 0 -4 -5 -5 -4
TotalStockholde 0 -88 -116 55 52
TotalLiabilitie 0 22 43 89 101
Cash Flow Statement
Year 20142015201620172018
NetIncome 0 -13 -25 -36 -65
Depreciation 0 1 1 0 0
DeferredIncomeT 0 0 0 0 0
StockBasedCompe 0 1 1 2 4
AccountsReceiva 0 -1 0 1 0
InventoryCS 0 0 0 0 0
AccountsPayable 0 0 1 3 -2
OtherWorkingCap 0 -1 0 10 3
OtherNonCashIte 0 0 0 0 1
NetCashProvided 0 -13 -22 -20 -52
InvestmentsInPP 0 0 -1 -1 -1
AcquisitionsNet 0 0 0 0 0
PurchasesOfInve 0 0 0 -28 -62
SalesMaturities 0 0 0 0 0
PurchasesOfInta 0 0 0 0 0
OtherInvestingA 0 0 -4 7 60
NetCashUsedForI 0 0 -5 -22 -2
DebtIssued 0 4 14 0 21
DebtRepayment 0 0 -2 0 -13
CommonStockIssu 0 0 0 72 57
CommonStockRepu 0 0 0 0 0
DividendPaid 0 0 0 0 0
OtherFinancingA 0 20 0 -4 1
NetCashProvided 0 25 44 68 66
NetChangeInCash 0 9 16 26 12
CashAtBeginning 0 8 17 32 59
CashAtEndOfPeri 0 17 32 59 71
Retained Earnings
Year 20142015201620172018
RetainedEarning -----84
NetIncome ----13-25
StockDividend ---9753
DividendPaid -----
RetainedEarning ----84-112
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE ----2
DeprAnnual 0---3-
CapitalExpendit 00001
NetPPE ---22
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0----
Amortization 0--2-1
NewPurchases 0---21
intAndGW -----
Selecta Biosciences Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Selecta Biosciences Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.